https://www.avient.com/news/polyone’s-new-bergamid-polyamide-improves-weld-strength-and-aesthetics-laser-welded-parts
With well-controlled laser transmission rates, multiple color choices and customized performance options, this new addition to the Bergamid portfolio allows manufacturers to produce high-performance parts with durable welds and smooth surfaces.
In addition, laser absorption can be controlled by adjusting the type of pigments.
https://www.avient.com/sites/default/files/2022-08/ColorMatrix Excelite Product Bulletin.pdf
Through accurate
and consistent metering, Excelite additives enable
greater control of production tolerances and improve
linear consistency.
This process allows
greater control over production tolerances, thus reducing scrap rates, improving quality, and optimizing
process capacity.
Some of the information arises from laboratory work with small-scale equipment which may not provide a reliable indication
of performance or properties obtained or obtainable on larger-scale equipment.
https://www.avient.com/sites/default/files/2023-01/Mevopur Healthcare Functional Additives_Laser Welding Additives for Medical Devices Application Bulletin.pdf
Avient uses a “systems approach” to develop the
laser welding solution most adapted to your project,
taking into consideration the following aspects:
• Transmitting and absorbing parts
• Polymer type and grade
• Dispersion of the additive in the final part
• Sufficient and consistent loading of the additive
• Part design: attention to flow separation at the
welding interface
• Color and opacitiy
• Quality control – e.g. establish suitable control
parameters (UV Visible Spectra)
• Laser wavelength and processing parameter
Mevopur™ Healthcare Functional Additives
formulated for laser welding are designed for use
in healthcare applications.
Some of the information arises from laboratory work with small-scale equipment which may not provide a reliable indication
of performance or properties obtained or obtainable on larger-scale equipment.
Please be aware that there are certain applications Avient’s Mevopur products have not been designed for, nor are they promoted or intended for use in: including, but not limited to long-term or permanent
implants, birth control devices, or plastic surgery.
https://www.avient.com/sites/default/files/resources/TRA%2520-%25202016%2520Plan%2520Summary.pdf
Use Targets
What is the targeted reduction in use of the toxic substance at the facility?
No quantity
Quantity Unit
or
What is the targeted timeframe for this reduction?
No quantity
Quantity Unit
or
What is the targeted timeframe for this reduction?
https://www.avient.com/sites/default/files/resources/PolyOne%2520IR%2520Presentation%2520-%2520Recast%2520Financial%2520Information%2520-%2520ASU%25202017-07%2520-%2520Pension%2520and%2520Postretirement%2520Costs.pdf
Microsoft PowerPoint - Recast Financial Information for Pension Standard v13
2013 to 2017 Recast GAAP
Financial Information for the
Adoption of ASU 2017-07:
Presentation of Net Periodic
Pension and Postretirement
Benefit Cost
April 26, 2018
POLYONE CORPORATION 2
Reflects quarterly GAAP financial adjustments for the adoption of ASU
2017-07.
For comparative purposes, we have recast our historical GAAP financial
information for 2013 to 2017.
Description
POLYONE CORPORATION 3
2013 to 2017 Recast GAAP Financial Information for the
Adoption of ASU 2017-07
Q1 Q2 Q3 Q4 YTD Q1 Q2 Q3 Q4 YTD Q1 Q2 Q3 Q4 YTD
Operating Income - As Previously Reported 56.3$ 73.1$ 55.5$ 58.1$ 243.0$ 56.0$ 49.3$ 57.9$ (12.6)$ 150.6$ 70.3$ 78.7$ 74.3$ 34.3$ 257.6$
Interest Cost 6.1 6.1 6.1 6.2 24.5 6.4 6.4 6.4 6.4 25.6 5.5 5.5 5.5 5.4 21.9
Expected Return on Plan Assets (9.3) (9.3) (9.3) (9.5) (37.4) (8.1) (8.1) (8.0) (8.0) (32.2) (8.2) (8.2) (8.2) (8.1) (32.7)
Mark to Market Adjustment - - - (44.0) (44.0) - - - 56.5 56.5 - - - 11.6 11.6
Operating Income - Recasted for ASU 2017-07 53.1$ 69.9$ 52.3$ 10.8$ 186.1$ 54.3$ 47.6$ 56.3$ 42.3$ 200.5$ 67.6$ 76.0$ 71.6$ 43.2$ 258.4$
Other Income (Expense), net - As Previously Reported 1.5$ (1.3)$ (1.5)$ -$ (1.3)$ (0.7)$ (0.4)$ (1.6)$ (1.4)$ (4.1)$ (0.6)$ (1.2)$ (1.7)$ 0.3$ (3.2)$
Interest Cost (6.1) (6.1) (6.1) (6.2) (24.5) (6.4) (6.4) (6.4) (6.4) (25.6) (5.5) (5.5) (5.5) (5.4) (21.9)
Expected Return on Plan Assets 9.3 9.3 9.3 9.5 37.4 8.1 8.1 8.0 8.0 32.2 8.2 8.2 8.2 8.1 32.7
Mark to Market Adjustment - - - 44.0 44.0 - - - (56.5) (56.5) - - - (11.6) (11.6)
Other Income (Expense), net - Recasted for ASU 2017-07 4.7$ 1.9$ 1.7$ 47.3$ 55.6$ 1.0$ 1.3$ -$ (56.3)$ (54.0)$ 2.1$ 1.5$ 1.0$ (8.6)$ (4.0)$
Q1 Q2 Q3 Q4 YTD Q1 Q2 Q3 Q4 YTD
Operating Income - As Previously Reported 70.4$ 81.8$ 72.0$ 62.1$ 286.3$ 84.0$ 80.0$ 67.7$ 45.8$ 277.5$
Interest Cost 5.3 5.3 5.3 5.3 21.2 4.9 4.9 4.9 5.0 19.7
Expected Return on Plan Assets (7.9) (7.9) (7.8) (7.8) (31.4) (6.9) (6.9) (6.9) (7.0) (27.7)
Mark to Market Adjustment - - - (8.4) (8.4) - - - 3.3 3.3
Operating Income - Recasted for ASU 2017-07 67.8$ 79.2$ 69.5$ 51.2$ 267.7$ 82.0$ 78.0$ 65.7$ 47.1$ 272.8$
Other Income (Expense), net - As Previously Reported -$ 0.1$ (0.1)$ 0.4$ 0.4$ (1.1)$ (1.4)$ (0.7)$ (0.9)$ (4.1)$
Interest Cost (5.3) (5.3) (5.3) (5.3) (21.2) (4.9) (4.9) (4.9) (5.0) (19.7)
Expected Return on Plan Assets 7.9 7.9 7.8 7.8 31.4 6.9 6.9 6.9 7.0 27.7
Mark to Market Adjustment - - - 8.4 8.4 - - - (3.3) (3.3)
Other Income (Expense), net - Recasted for ASU 2017-07 2.6$ 2.7$ 2.4$ 11.3$ 19.0$ 0.9$ 0.6$ 1.3$ (2.2)$ 0.6$
2013 2014 2015
2016 2017
https://www.avient.com/sites/default/files/2025-04/Supplier Code of Conduct FV_Eng.pdf
Activities
that have the potential to adversely impact human
health or the environment shall be appropriately
managed, measured, controlled, and handled prior
to release of any substance into the environment
Comply with all applicable import and export
controls, as well as trade compliance and antitrust
laws
Inform Avient of financial, economic, supply changes
(including origin or conflict status of 3TG metals),
government regulations or other materials
conditions that could affect ongoing operations or
operating decisions, or if the company has been
debarred as a government contractor
https://www.avient.com/sites/default/files/2021-10/information-systems-use-policy-final-9.1.2021.pdf
http://polynet/ethics/Portals/23/documents/Cyber%20and%20Data%20Incident%20Response%20Policy/Cyber_Incident_Response_Policy-September%202018_EN%20-%20v1.pdf
http://polynet/ethics/Portals/23/documents/Cyber%20and%20Data%20Incident%20Response%20Policy/Cyber_Incident_Response_Policy-September%202018_EN%20-%20v1.pdf
Confidential 6 Avient IT Department
Information Systems Use Policy September 1, 2021
APPENDIX A: DEFINITIONS
In addition to those terms defined within the body of this Policy, the following definitions are
used:
“Avient Data” – includes (a) all data and information generated, stored, collected, or processed by Avient
through Information Systems; (b) all information under the control of Avient and originating from,
belonging to, or received from customers, suppliers, or third parties; (c) all data and information regarding
intellectual property of Avient; and (d) purely intra-Avient information connected to individual employees,
such as Information System usernames, passwords, and company ID.
For example, Personal Data could be an individual’s Social Security Number (SSN), name,
address, date of birth, tax identification number or equivalent, credit or debit card number, or financial
account number.
Information Systems” – any software, hardware, firmware, data networks, physical or remote storage
media, or other digital services used, owned, accessed, controlled, leased, or operated by Avient.
https://www.avient.com/sites/default/files/2023-06/Supplier Code of Conduct FV.pdf
Activities
that have the potential to adversely impact human
health or the environment shall be appropriately
managed, measured, controlled, and handled prior
to release of any substance into the environment
Comply with all applicable import and export
controls, as well as trade compliance and antitrust
laws
Inform Avient of financial, economic, supply changes
(including origin or conflict status of 3TG metals),
government regulations or other materials
conditions that could affect ongoing operations or
operating decisions, or if the company has been
debarred as a government contractor
https://www.avient.com/sites/default/files/resources/IR_Deck_11.4.19.pdf
USE OF
NON-GAAP
MEASURES
PolyOne Corporation 3
• This presentation includes the use of both GAAP (generally accepted
accounting principles) and non-GAAP financial measures.
The non-GAAP
financial measures include: adjusted EPS, adjusted operating income, and
return on invested capital
A reconciliation of each non-GAAP financial measure with the most
directly comparable GAAP financial measure is attached to this
presentation which is posted on our website at www.polyone.com.
https://www.avient.com/sites/default/files/resources/11.30.18%2520Investor%2520Presentation%2520V1.pdf
USE OF
NON-GAAP
MEASURES
PolyOne Corporation 3
• This presentation includes the use of both GAAP (generally accepted
accounting principles) and non-GAAP financial measures.
The non-GAAP
financial measures include: adjusted EPS, adjusted operating income, and
return on invested capital
A reconciliation of each non-GAAP financial measure with the most
directly comparable GAAP financial measure is attached to this
presentation which is posted on our website at www.polyone.com.